These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27139481)

  • 41. Antiviral activity of berberine and related compounds against human cytomegalovirus.
    Hayashi K; Minoda K; Nagaoka Y; Hayashi T; Uesato S
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1562-4. PubMed ID: 17239594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acyclic guanosine analogs as inhibitors of human cytomegalovirus.
    Wahren B; Larsson A; Rudén U; Sundqvist A; Sølver E
    Antimicrob Agents Chemother; 1987 Feb; 31(2):317-20. PubMed ID: 3032096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and validation of a non-radioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet.
    Ducancelle A; Alain S; Petit F; Sanson Le Pors MJ; Mazeron MC
    J Virol Methods; 2007 May; 141(2):212-5. PubMed ID: 17197042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate.
    Abele G; Eriksson B; Harmenberg J; Wahren B
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1137-42. PubMed ID: 2847643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opposite effect of two cytomegalovirus DNA polymerase mutations on replicative capacity and polymerase activity.
    Martin M; Azzi A; Lin SX; Boivin G
    Antivir Ther; 2010; 15(4):579-86. PubMed ID: 20587851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation.
    Göhring K; Wolf D; Bethge W; Mikeler E; Faul C; Vogel W; Vöhringer MC; Jahn G; Hamprecht K
    J Clin Virol; 2013 May; 57(1):43-9. PubMed ID: 23375740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of ganciclovir-resistant human cytomegalovirus replication by Kampo (Japanese herbal medicine).
    Murayama T; Yamaguchi N; Iwamoto K; Eizuru Y
    Antivir Chem Chemother; 2006; 17(1):11-6. PubMed ID: 16542001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonnucleoside pyrrolopyrimidines with a unique mechanism of action against human cytomegalovirus.
    Jacobson JG; Renau TE; Nassiri MR; Sweier DG; Breitenbach JM; Townsend LB; Drach JC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1888-94. PubMed ID: 10428908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory effects of tricin derivative from Sasa albo-marginata on replication of human cytomegalovirus.
    Akuzawa K; Yamada R; Li Z; Li Y; Sadanari H; Matsubara K; Watanabe K; Koketsu M; Tuchida Y; Murayama T
    Antiviral Res; 2011 Sep; 91(3):296-303. PubMed ID: 21745500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Analysis of ganciclovir-resistant cytomegalovirus].
    Eizuru Y
    Nihon Rinsho; 1998 Jan; 56(1):151-5. PubMed ID: 9465681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions.
    Komazin-Meredith G; Chou S; Prichard MN; Hartline CB; Cardinale SC; Comeau K; Williams JD; Khan AR; Peet NP; Bowlin TL
    Antimicrob Agents Chemother; 2014; 58(1):274-8. PubMed ID: 24145545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus.
    Chou S; Lurain NS; Thompson KD; Miner RC; Drew WL
    J Infect Dis; 2003 Jul; 188(1):32-9. PubMed ID: 12825168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir.
    Lee GC; Lee DG; Choi SM; Yoo JH; Park SH; Choi JH; Min WS; Cho OH; Lee CH; Shin WS
    J Clin Microbiol; 2005 Oct; 43(10):5003-8. PubMed ID: 16207954
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel DNA polymerase mutations conferring cytomegalovirus resistance: input of BAC-recombinant phenotyping and 3D model.
    Hantz S; Cotin S; Borst E; Couvreux A; Salmier A; Garrigue I; Merville P; Mengelle C; Attal M; Messerle M; Alain S
    Antiviral Res; 2013 Apr; 98(1):130-4. PubMed ID: 23415883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resistance of human cytomegalovirus to ganciclovir/valganciclovir: a comprehensive review of putative resistance pathways.
    Komatsu TE; Pikis A; Naeger LK; Harrington PR
    Antiviral Res; 2014 Jan; 101():12-25. PubMed ID: 24184129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
    Fischer L; Laib Sampaio K; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2013 Dec; 100(3):575-7. PubMed ID: 24120366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet.
    Tchesnokov EP; Gilbert C; Boivin G; Götte M
    J Virol; 2006 Feb; 80(3):1440-50. PubMed ID: 16415021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.
    Tchesnokov EP; Obikhod A; Schinazi RF; Götte M
    J Biol Chem; 2009 Sep; 284(39):26439-46. PubMed ID: 19622750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of HHV-6 mutations in solid organ transplant recipients at the onset of cytomegalovirus disease and following treatment with intravenous ganciclovir or oral valganciclovir.
    Bounaadja L; Piret J; Goyette N; Boivin G
    J Clin Virol; 2013 Sep; 58(1):279-82. PubMed ID: 23871165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
    Shaw T; Mok SS; Locarnini SA
    Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.